• Explore /
  • Poster
  • / A phase 2 clinical trial of axitinib and avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (ACC).

A phase 2 clinical trial of axitinib and avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (ACC).

Abstract Poster

Authors

Renata Ferrarotto

Renata Ferrarotto

Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Renata Ferrarotto , Diana Bell , Lei Feng , Kaiyi Li , Frank Mott , George R. Blumenschein , Luana Guimaraes de Sousa , Mehmet Altan , Mario L. Marques-Piubelli , Eduardo Andreazza Dal Lago , Diana Kaya , Myrna Godoy , Michael Elliot Kupferman , Bonnie S. Glisson , Adel K. El-Naggar , Yasir Y Elamin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Other Head and Neck Cancer (Salivary, Thyroid)

Clinical Trial Registration Number

NCT03990571

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6019)

DOI

10.1200/JCO.2022.40.16_suppl.6019

Abstract #

6019

Poster Bd #

11

Abstract Disclosures

Similar Posters

First Author: Elizabeth Katherine Lee

First Author: Chuanliang Cui

First Author: Camilla Oliveira Hoff

First Author: Elizabeth Katherine Lee